Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 7Terminated 5Unknown 4Active not recruiting 3Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 4

Conditions

Multiple Myeloma 4Stomach Neoplasms 2Lymphoma, B-Cell, Marginal Zone 2Persistence of Infection With Helicobacter Pylori 1Lymphoma, Non-Hodgkin 1Lymphoma 1Infections 1Familial primary gastric lymphoma 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Dexamethasone 64Cyclophosphamide 40Bortezomib 37Melphalan 24Lenalidomide 23Thalidomide 17pomalidomide 16fludarabine 12daratumumab 11carfilzomib 10Filgrastim 8Doxorubicin 8Busulfan 6Prednisone 5Peripheral Blood Stem Cell Transplantation 5Bendamustine Hydrochloride 5selinexor 4sargramostim 4isatuximab 4fludarabine phosphate 4Surveys and Questionnaires 4Etoposide 4Clarithromycin 4Calcium Dobesilate 4liposomal doxorubicin 3ixazomib 3Radiotherapy 3Neoadjuvant Therapy 3Mycophenolic Acid 3Methylprednisolone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Multiple Myeloma × Clarithromycin × Clear all
NCT02575144 2022-02-01

GEM-CLARIDEX

PETHEMA Foundation

Phase 3 Unknown
286 enrolled
Plasma cell

Multiple Myeloma

NCT04287660 2021-10-25

Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients

The First Affiliated Hospital of Soochow University

Phase 3 Unknown
20 enrolled
Plasma cell

Multiple Myeloma

NCT02248428 2017-09-06

CTd

Jinling Hospital, China

Phase 3 Unknown
130 enrolled
Plasma cell

Multiple Myeloma

NCT02624440 2015-12-08

SUTRICA

Aalborg University Hospital

Phase 2 Unknown
300 enrolled
Plasma cell

Infections, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡